Research Article
Antimicrobial Resistance Pattern and Their Beta-Lactamase Encoding Genes among Pseudomonas aeruginosa Strains Isolated from Cancer Patients
Table 2
Resistance rates for clinical P. aeruginosa isolates.
| |
Antibiotic | Number (%) of resistant isolates | Total isolates
() | Imipenem susceptible
() | Imipenem intermediate
() | Imipenem resistant
() |
| | -lactams | | | | | | Cefuroxime | 107 (87.7%) | 51 (77.2%) | 8 (100%) | 48 (100%) | | Cefoperazone | 98 (80.3%) | 43 (65.2%) | 8 (100%) | 47 (97.9%) | | Ceftazidime | 74 (60.6%) | 23 (34.8%) | 8 (100%) | 43 (89.5%) | | Meropenem | 56 (45.9%) | 3 (4.5%) | 7 (87.5%) | 46 (95.8%) | | Aztreonam | 55 (45.1%) | 28 (42.4%) | 3 (37.5%) | 24 (50%) | | Imipenem | 48 (39.3%) | 66 (100%) | 8 (100%) | 48 (100%) | | Piperacillin/tazobactam | 31 (25.4%) | 4 (6.1%) | 7 (87.5%) | 20 (41.6%) | | Non -lactams | | | | | | Gentamicin | 61 (50%) | 13 (19.7%) | 5 (62.5%) | 43 (89.5%) | | Ciprofloxacin | 53 (43.4%) | 17 (25.8%) | 5 (62.5%) | 31 (64.5%) | | Amikacin | 40 (32.8%) | 9 (13.6%) | 7 (87.5%) | 24 (50%) | | Polymyxin B | 3 (2.4%) | 0 (0.0%) | 1 (12.5%) | 2 (4.2%) |
|
|
